American Society of Preventive Oncology/Prevent Cancer Foundation2009 Cancer Prevention Research FellowshipFor Young Scientists at the Postdoctoral or Clinical Fellow Level2009 Research Fellowship in Cancer Prevention Research: This Fellowship, sponsored by the Prevent Cancer Foundation, will provide a two-year award of $40,000 per year to a young scientist in the U.S. or engaged in meritorious cancer prevention research or presenting a proposal deemed to have potential for advancing the general goals of cancer prevention. Letter of IntentEach applicant is required to submit a very brief letter of intent (via e-mail, fax) by November 14, 2008.
EligibilityCandidates must have completed the MD, PhD, or other doctoral degree. Candidates must currently be a postdoctoral or clinical research fellow and must have been a fellow for at least one year but not more than 4 years prior to the year of the award. Academic faculty holding the rank of assistant professor or higher, graduate or medical students, federal government employees and employees of private industry are not eligible. A candidate need not be a member of the American Society of Preventive Oncology (ASPO) at the time of application, but must be nominated by an ASPO member. Student members may not be nominators.Selection ProcessApplications will receive careful scientific evaluation by a multidisciplinary committee consisting of ASPO members who are experts in basic and clinical cancer prevention research. Applications must be received in complete form by December 3, 2008. An application can be found at www.aspo.org
American Society of Hematology Research Training Award for Fellows
Goals of this program are: To encourage and enable fellowship programs to provide time for research (clinical, basic science, or translational). To promote mentorship of hematology trainees by outstanding faculty members. To produce, on a yearly basis, clinician scientist candidates for academic track positions. To provide bridging funds for trainees who need more time to generate sufficient expertise to be competitive when applying for K award funding. Support The ASH Research Training Award for Fellows will, on a three-year pilot basis, grant $50,000 for a one-year period to third- and fourth-year trainees (at time of the award) in training who are not yet eligible for the ASH Scholar Awards (fellow category). This award is intended to be used primarily for salary support for the applicant. However, up to $5,000 may be allocated for research supplies and reagents, and up to $1,000 may be allocated for travel to the ASH annual meeting (no other meetings are eligible for this allocation). Each of the non-salary support portions of the budget must be accompanied by a clear justification. Awards will be activated on July 1 and conclude on June 30 of the year following activation. Monies cannot be used toward salary/benefits for the mentor or toward an institution's overhead or indirect costs. Payments will be made to the appropriate financial officer of the institution. Eligibility Criteria The ASH Research Training Award for Fellows is intended for upper-level fellows who meet the following criteria. At the time of application (January 5, 2009): The applicant must either be an ASH Associate member or submit a membership application.
The applicant must not have any other career-development funding.
The applicant must have completed at least six months, but less then 18 months of post-doctoral research training. The proposed research must be in hematology, hematology/oncology, or a hematology-related area. The applicant should be planning to pursue an investigative career in hematology research. The applicant must have clear and documented support of a funded mentor (funding may be NIH, federal, foundation, or private) and documented support from the program director for dedicated research time. The applicant must have a mentor who is an ASH member. If the mentor is not an active ASH member, a letter of support from an ASH member must be included. At least 75 percent of the applicant's full-time professional efforts must be devoted to research during the funded period. No more then one awardee per fellowship program per year, and no more than one award per medical school per year. For this purpose, ASH defines medical school so that it encompasses all sub-institutions. Requirements at the time of the award (July 1, 2009). The applicant must: Be an MD, DO, DO/PhD, or MD/PhD Have completed one year of clinical training within a hematology, hematology/oncology, or hematology-related training program in the United States or Canada Be a third- or fourth-year trainee in a hematology, hematology/oncology, or hematology-related training program in the United States or Canada The ASH Research Training Award for Fellows supports the same categories of research as the ASH Scholar Awards – basic research and clinical/translational research. Letter-of-Intent Requirements Applicants must submit a letter of intent by November 3, 2008, that includes the following: A completed letter-of-intent form Applicant's curriculum vitae to confirm eligibility An abstract of proposed research study and a description if its relevance of the study to hematology Application Requirements Eligible candidates will be asked to complete an application which must include a: Detailed description of the proposed research study,including information on the significance, originality, hypothesis, feasibility, and methodology Letter confirming the availability of project specific institutional resources to support the proposed project Co-authored, detailed career-development plan describing the applicant's current and future academic and research career plans, and the mentor's vision for mentor-applicant interaction Letter of support from an ASH member (if the identified mentor is not an ASH member) Biosketch for the mentor and the applicant including other support (active and pending); there is a four-page limit for each biosketch Budget Letter of support from the program director which must include statements: indicating that a minimum of 75 percent of the recipient's time will be dedicated to research defining the recipient's anticipated clinical responsibilities during the award period describing the training program's financial need for this award describing the salary support resources for all of the program's trainees (to include institutional funding, NIH training grants, etc.) identifying the source(s) of the applicant's other salary support if he/she is a recipient of this award Selection The selection of award winners will be made by a study section appointed by members of the Award Study Section. Criteria for selection are: The qualifications and experiences of the applicant. Factors to be considered include, but are not limited to the potential for future independent investigation and commitment to a career in hematology research Quality of the mentor and the plan for mentor/applicant interaction and career development The significance, feasibility, and originality of the proposed hypothesis, research, and methodology A focus on hematology research Availability of institutional resources to support the proposed project Ten finalists will be selected to be interviewed by the Award Study Section. All finalists for the award must be available for face-to-face interviews with the Study Section in March. The interviews will focus on determining the applicants' commitment to hematology and potential for success. Timeline Letter of intent due November 3, 2008 Application due January 5, 2009 Finalist interviews March 2009 Notification of awards April 2009 Activation of award July 1, 2009
American Society of Hematology 1900 M St., NW, Suite 200 Washington, DC 20036 Tel: 202-776-0544 Fax: 202-776-0545 E-Mail: ash@hematology.org
American Society of Hematology Alternative Training Pathway Grant
Purpose The need for clinicians and clinical/translational researchers in hematology-related disciplines is strong. In recognition of the changing role of the hematologist and of current and future anticipated workforce needs, training opportunities for physicians interested in hematology-related careers must be expanded. The American Society of Hematology invites Training Program Directors and other educators to submit proposals for novel training initiatives that will augment existing training programs. The Alternative Training Pathway Grant is intended to address the needs of trainees with primary interest in various aspects of hematology and to encourage competency-based training in established and emerging areas of hematology. Additionally, the grant is intended to produce clinicians and clinician-scientists with the skills to apply the full array of technologies made available through advancing medical sciences for the management of complex hematologic problems. Description of Need The Alternative Training Pathway Grant is intended to foster the development and implementation of creative new curricula for trainees in clinical and clinical/translational hematology and related fields. A growing number of trainees are expressing an interest in pursuing hybrid careers (e.g., medicine/pediatrics) and/or a desire to become trained in both clinical care and laboratory medicine (e.g., transfusion medicine or directing hemostasis laboratories). The Alternative Training Pathway Grant is designed to allow training program directors to develop a curriculum that meets these new demands. Support Grants of up to $50,000 will be awarded to support the development and implementation of novel hematology-related training programs as an alternative to traditional training programs. The award may be expended over a one- to two-year period of time. No institutional overhead (i.e., indirect) costs will be supported by this grant. Eligibility Applicants must be Active Members of the American Society of Hematology (ASH) at institutions with an accredited training program(s) in adult or pediatric hematology or hematology/medical oncology, or in other hematology-related disciplines (e.g., pathology specialties) in the United States, Canada, or Mexico. Awards are limited to only one application per institution. Awardees must commit to providing progress reports and final reports as defined in the terms of the grant. Letter of Intent To be considered for this award, prospective applicants must submit a completed letter of intent (LOI) via e-mail no later then 5:00 p.m. EST, on Monday, February 2, 2009. The LOI must include (1) descriptive title of the proposed alternative training pathway; (2) contact information for the principal investigator; (3) names of other key personnel; (4) participating institution(s); and; (5) an abstract of the proposed alternative training pathway.
Key Dates: Letter of Intent Due: February 2, 2009 Application Due: March 27, 2009 Peer Review: April-May 2009 Committee Review: May 2009 Award Notification Date: June 2, 2009 Funds Activated: July 1, 2009 Questions regarding this application and the ASH Alternative Training Pathway Grant should be directed to Joe Basso, Training Manager, at jbasso@hematology.org or 202-552-4910.
Federal Pharmacists Incentive Grants Application Deadline: December 15, 2008The APhA Foundation will award grants in the amount of $2,000 for projects to be initiated for military or civil service pharmacists working in the Army, Air Force, Coast Guard, Navy, Department of Veterans Affairs or the Public Health Service. The grants provide seed money to help pharmacists in federal sector practice settings with start-up costs to establish a new pharmaceutical care project or to use as continuing development costs to expand an already existing project, and to encourage them to share their experiences with other pharmacists within the federal sector. The Federal Pharmacists Incentive Grants program is intended to focus pharmacists’ attention on the need to re-engineer their practices along lines that incorporate more specific patient-centered services and enhance health care delivery with the use of today’s technology. The project should concentrate on a new, innovative patient care service or expand an already existing service that is of significance to the pharmacy profession and that can be evaluated for its relevance. The incentive grant project proposals must be in one of the following areas: * Osteoporosis * Oncology * Hepatitis-C * HIV/AIDS * Other Infectious Diseases * Medication Therapy Management ServicesThe APhA Foundation has awarded incentive grants to pharmacists in a variety of practice settings for over ten years. This is the second year for the Federal Pharmacists Incentive Grants program which is made possible with support from The Roche Foundation.
While the APhA and APhA Foundation’s headquarter building undergoes a massive renovation and expansion, the current address for the APhA Foundation is:1100 15th Street, NW, Suite 400Washington, DC 20005-1707Telephone: (202) 429-7565Email: info@aphafoundation.org
American Head and Neck Society/American Academy of Otolaryngology - Head and Neck Surgery Young Investigator Combined Award
Open to new full time academic surgeons working on contemporary basic or clinical research skills focused on neoplastic disease of the head and neck in the U.S. or Canada. Two year, non-renewable, $40,000 maximum ($20,000 per year), one available annually.
The purpose of this award is to support a collaborative AHNS/AAO-HNSF research project by fosteringthe development of contemporary basic or clinical research skills focused on neoplastic disease of thehead and neck among new full-time academic surgeons. The award is intended as a preliminary step inclinical investigator career development and is expected to facilitate the recipient’s preparation of a morecomprehensive individualized research plan suitable for submission to the National Institutes of Health orcomparable funding agency.ELIGIBILITYApplicants must be physicians with demonstrated potential for excellence in research and teaching andserious commitment to an academic research career in head and neck surgery. Applicants must bemembers or candidate members of the American Academy of Otolaryngology-Head and Neck Surgeryand/or the American Head and Neck Society. Priority will be given to fellows or junior faculty who havecompleted residencies or fellowships within four years of the application receipt date. All candidatesmust be sponsored by the Chair of his/her Division or Department and by an official representative of theinstitution which would administer the Award and in whose name the application is formally submitted.Former ASHNS/AHNS or Foundation research grant recipients are eligible to compete for theAHNS/AAO-HNSF grant. Individuals who have already competed successfully for independent researchgrant support from a private or Federal funding agency are ineligible for this Award.CONDITIONSResearch supported by this award should be specifically directed toward the pathophysiology, diagnosis,prevention, or treatment of head and neck neoplastic disease, and may be either basic orclinical/transnational in approach. Proposed projects shall be designed in collaboration with a preceptorinvestigator and approved by the candidate's department chairperson and institution. While notspecifically required, proposals which aim to introduce new knowledge and methodology from otherdisciplines to research in head and neck disease, or which demonstrate collaborative effort with membersof other related disciplines are encouraged. Projects must be designed so as to yield useful informationwithin the period of award, but priority will be given to projects that are also innovative with promise todevelop into new long-range or expanded research programs capable of attracting funding from othersources. Applications must be accompanied by a letter of support from the applicant’s Department Chairand Preceptor verifying that the applicant will be permitted to devote an appropriate amount of time to theconduct and timely completion of the proposed research project. Applicants must obtain letters ofsupport/understanding from all key personnel on the project. The grantee must submit an interimprogress report to the Foundation at the end of the first year of the award.TERMS1. Amount: $40,000 maximum ($20,000 per year)2. Period: 24 months, non-renewable
All applicants must submit a Letter of Intent online no later than midnight Eastern Standard TimeDecember 15. The letter of intent includes the title of the project, the principal investigator, and anabstract of the work. This will facilitate planning review requirements.
American Head and Neck Society Alando J. Ballantyne Resident Research Pilot Grant
For the best grant application by a resident in the U.S. or Canada. One year, non-renewable, $10,000, one available annually.
The purpose of this award is to support basic, translational, or clinical research projects in head and neckoncology. Clinical or translational research studies are strongly encouraged and should be specificallyrelated to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neckneoplastic disease. The Alando J. Ballantyne Resident Research Pilot Grant memorializes Alando J.Ballantyne, M.D., a giving teacher, dedicated surgeon, and a devoted husband and father.ELIGIBILITYThis grant is open to resident in U.S. or Canadian training programs. Previous AHNS or AAO-HNSFoundation research grant recipients are eligible to compete for this grant. However, candidates whohave successfully obtained funding from a private or federal funding agency for the same research areineligible. Candidates who have applied for support of the same research from other funding sources, andwho are notified of an award from both another agency and from AHNS must choose only one of theawards.CONDITIONSResearch supported by this award should be specifically directed toward the pathogenesis,pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may beeither basic or clinical/translational in approach. While not specifically required, proposals which aim tointroduce new knowledge and methodology from other disciplines to research in head and neck disease,or which demonstrate collaborative effort with members of other related disciplines are encouraged.Projects must be designed so as to yield useful information within the period of award, but priority will begiven to projects that are also innovative with promise to develop into new long-range or expandedresearch programs capable of attracting funding from other sources. The grant application must beaccompanied by letters of support from the Chair of the candidate’s academic department and from theprincipal scientific advisor or mentor. These letters are to indicate a general level of support of theapplicant, the fact that the Department will make time, space, and other resources accessible forcompletion of the project, and that the applicant will have appropriate supervision/support throughout theperiod of the grant. Applicants must obtain letters of support/understanding from all key personnel on theproject.TERMS1. Amount: $10,000 maximum2. Period: 12 months, non-renewable
American Head and Neck Society Pilot Grant
Open to Medical Students, residents, PhD, and junior faculty residing in the U.S. and Canada to support basic, translational, or clinical research projects in head and neck oncology. One year, $10,000, one available annually.
The purpose of this award is to support basic, translational, or clinical research projects in head and neckoncology. Clinical or translational research studies are strongly encouraged and should be specificallyrelated to the prevention, diagnosis, treatment, outcomes, or pathophysiology of head and neckneoplastic disease.ELIGIBILITYCandidates for this award should reside in the U.S. or Canada, be medical students, residents, Ph.D.s orfaculty members at the rank of associate professor or below. Previous AHNS or AAO-HNS Foundationresearch grant recipients are eligible to compete for this grant. However, candidates who havesuccessfully obtained funding from a private or federal funding agency for the same research areineligible. Candidates who have applied for support of the same research from other funding sources, andwho are notified of an award from both another agency and from AHNS must choose only one of theawards.CONDITIONSResearch supported by this award should be specifically directed toward the pathogenesis,pathophysiology, diagnosis, prevention, or treatment of head and neck neoplastic disease, and may beeither basic or clinical/translational in approach. While not specifically required, proposals which aim tointroduce new knowledge and methodology from other disciplines to research in head and neck disease,or which demonstrate collaborative effort with members of other related disciplines are encouraged.Projects must be designed so as to yield useful information within the period of award, but priority will begiven to projects that are also innovative with promise to develop into new long-range or expandedresearch programs capable of attracting funding from other sources.The grant application must be accompanied by letters of support from the Chair of the candidate’sacademic department and from the principal scientific advisor or mentor. These letters are to indicate ageneral level of support of the applicant, the fact that the Department will make time, space, and otherresources accessible for completion of the project, and that the applicant will have appropriatesupervision/support throughout the period of the grant. Applicants must obtain letters ofsupport/understanding from all key personnel on the project.TERMS1. Amount: $10,000 maximum2. Period: One year, non-renewable
Friends For An Earlier Breast Cancer Test awards funding and grants for cancer research that demonstrates the potential for discovering earlier methods of breast cancer detection, such as a biological test. Through breast cancer funding research with specifically focused seed money grants, money directed from Friends is leveraged to help researchers pursue promising ideas. As a result of this preliminary work, it can be determined if research projects should be continued, ended, or altered. Our Medical Advisory Board annually selects the most worthy projects to receive funding. Without the opportunity for exploration worthy of new ideas, the disease of breast cancer can only change incrementally.
Deadline for application is December 1st.
Telephone:Toll free: 888-792-3062Local: 336-286-6620Fax: 336-286-6680Email:Business Office: friends@earlier.org
12345next